FDA Panel To Review Pfizer Vaccine For Children

The video discusses an FDA panel meeting to review Pfizer's COVID-19 vaccine for children aged 5 to 11, highlighting its 90% efficacy against symptomatic disease. The process involves FDA recommendations, followed by CDC guidance. The White House plans to distribute vaccines through pediatricians, hospitals, and schools. Despite most parents willing to vaccinate their children, some hesitancy remains, with polls indicating that mandates or full FDA approval could influence decisions.

How is the White House planning to roll out the COVID vaccine for children?

What factors influence parents' willingness to vaccinate their children according to recent polling?